CD47 promotes myeloma cell growth through JAK–STAT3/MYC signalling and is targetable by ruxolitinib

Omar Faruq, Deepak Iyer, Patrick Wang, Mariusz Shrestha, Cuihong Wei, Aaron D. Schimmer, Hong Chang
British Journal of Haematology · Wiley · 2026-11-10 · DOI: 10.1111/bjh.70736

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles